Eli Lilly Looks Over Its Shoulder After Novo Wins FDA Panel Backing for Diabetes Drug
D Pact With CureVac
3 Under-the-Radar Bay Area Biotechs That Could Double in 2018
Visterra Inks $1B Deal With This Bay Area Biotech
Alnylam Jumps on $1B RNAi Pact With Vir Biotechnology
Shire Under Pressure to Break Up the Business
Ignyta Stock Booms on Promising Mid-Stage Lung Cancer Data
Forty Seven Bags $75M, Bringing in a Total of $150M in Venture Capital
Arthrex to Create 1,000 Jobs With New $74M Facility
Reckitt to Break Up Company in Restructuring
This Massachusetts Pharma Doubled Its Market Cap in 2017, What's Next?
D Execs Quietly Step Down